Hyperthermia and radiotherapy in bladder cancer.
Hyperthermia represents a unique, safe, and advantageous methodology for improving therapeutic strategies in the management of bladder cancer. This modality has shown promise in contributing to treatment regimens for both superficial and muscle-invasive disease. Especially in conjunction with intravesical chemotherapy, systemic therapy, and radiotherapy, hyperthermia shows particular synergistic benefit. As such, it should be explored further through clinical use and clinical trial in conjunction with currently available techniques and emerging technologies. However, to conceptualise the way forward, it is particularly important to understand the current challenges to widespread use of non-invasive, bladder-sparing approaches and the current state of bladder cancer care. As such, in the following article, we have focused on not only the rationale for concurrent radiotherapy and hyperthermia, but also the clinical landscape in bladder cancer as a whole.
a Department of Radiation Oncology , University of Maryland Medical Center , Baltimore , Maryland , USA ;
James William
JW
Snider
b Department of Radiation Oncology, KSA-KSB, Kantonsspital Aarau , Aarau , Switzerland.
Niloy Ranjan
NR
Datta
a Department of Radiation Oncology , University of Maryland Medical Center , Baltimore , Maryland , USA ;
Zeljko
Z
Vujaskovic
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D006979:Hyperthermia, Induced; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000628:therapy*
D000970:Antineoplastic Agents
Bladder cancer; hyperthermia; radiation; radiotherapy; thermoradiotherapy